Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002668 · ClinicalTrials.gov registry record · NA
Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer
A NA study, sponsored by Eastern Cooperative Oncology Group.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT00002668: Clinical Trial NA study, sponsored by Eastern Cooperative Oncology Group.
NCT00002668 is a NA study that was terminated before completion, run by Eastern Cooperative Oncology Group. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002668, a NA study, was terminated before completion, sponsored by Eastern Cooperative Oncology Group.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
RATIONALE: An outpatient educational and behavioral skills training program may help patients with metastatic breast or prostate cancer live longer and more comfortably. PURPOSE: This randomized clinical trial studies whether an outpatient educational and behavioral skills training program will improve pain control in patients who have metastatic or recurrent breast or prostate cancer.
Primary Outcome
Change in worst pain from baseline to day 15
Interventions
- BEHAVIORAL Observation
- BEHAVIORAL Educational Intervention and Behavioral Skills Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 1996-02-14 |
| Est. Completion | 1998-09 |
| Phase | NA |
Why NCT00002668 stopped before completion
NCT00002668 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Observation is the first listed.
NCT00002668 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002668 about?
NCT00002668 is a clinical study titled "Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer". RATIONALE: An outpatient educational and behavioral skills training program may help patients with metastatic breast or prostate cancer live longer and more comfortably. PURPOSE: This randomized clinical trial studies whether an outpatient educational and behavioral skills training program will imp...
What is the current status of trial NCT00002668?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 1996-02-14. Estimated completion is 1998-09.
What interventions are being tested in trial NCT00002668?
The interventions under investigation include: Observation (BEHAVIORAL), Educational Intervention and Behavioral Skills Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT00002668?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00002668's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI